Recombinant PDGFRA (Olaratumab Biosimilar) anticorps
Aperçu rapide pour Recombinant PDGFRA (Olaratumab Biosimilar) anticorps (ABIN7829428)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Fonction
- Anti-PDGFRA(olaratumab biosimilar) mAb
-
Isotype
- IgG1, K214R, kappa
-
-
-
-
Indications d'application
- ELISA 1:5000-10000, Flow Cyt 1:100
-
Commentaires
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.
-
Date de péremption
- 12 months
-
-
- PDGFRA (Olaratumab Biosimilar)
-
Autre désignation
- Olaratumab Biosimilar
-
Classe de substances
- Biosimilar
-
Sujet
-
Synonyms Target:platelet-derived growth factor receptor alpha subunit, PDGFR2, CD140a
Synonyms Antibody:3G3, IMC-3G3, IMC3G3, LY3012207 -
UniProt
- P16234
Antigène
-